Faculty profile

Vijay Ramaswamy

ResearcherDevelopmental Stem Cell BiologyUniversity of Toronto

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Toronto directory, so their courses and email address may be missing. Find their university profile.

Vijay Ramaswamy

Researcher

Developmental Stem Cell Biology

Health Sciences

University of Toronto

Toronto, Ontario, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
91 publications in the last five years, latest in 2026.
Senior (last) author on 11 recent papers, a sign of leading a research group.
Principal investigator on 4 research grants (4 CIHR), most recently in 2025.
Supervised 1 trainee who won CIHR awards, most recently in 2021.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

268

Publications

5,189

Citations

h-index

115

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Ependymoma Pediatric Cancer Antisense Oligonucleotides Fusions Medulloblastoma Brain Cancer Functional Genomics Sonic Hedgehog

Latest papers

Survival Outcomes and Complications Among Canadian Children With Retinoblastoma: A Population-Based Report From CYP-C.
Pediatric blood & cancer · 2026
Posterior fossa ependymoma: a comprehensive review of molecular classification, management guidelines, and clinical outcomes (Part I of ependymomas across compartments).
Journal of neuro-oncology · 2026
TRAM-01: A phase 2 study of trametinib for pediatric patients with neurofibromatosis type 1 and plexiform neurofibromas.
Neuro-oncology · 2026

All 268 publications

Latest funding

Targeting Gene Fusions in Pediatric Brain Tumors: A Personalized Medicine Approach
CIHR · 2025 · Nominated PI
$1,491,750
Exploiting therapeutic vulnerabilities to identify new treatments for high-risk SHH medulloblastoma
CIHR · 2022 · Nominated PI
$1,285,200
OPTIMISE: Optimal precision therapies to customise care in childhood and adolescent cancer
CIHR · 2022 · Co-investigator
$545,625

All 10 grants and awards

From the 150 most recent of 268 publications.

Survival Outcomes and Complications Among Canadian Children With Retinoblastoma: A Population-Based Report From CYP-C.

Sassine S, Trudeau-Ferrin O, Laverdière C, Hamel P, Superstein R, Koukoui B, Provost C, Nathan PC, Ramaswamy V, Shaikh F, Gallie B, Mallipatna A, Kletke S, Dimaras H, Coltin H

Pediatric blood & cancer2026

DOI: 10.1002/1545-5017.70316 PMID: 41968807

Posterior fossa ependymoma: a comprehensive review of molecular classification, management guidelines, and clinical outcomes (Part I of ependymomas across compartments).

Koutsouras GW, Rivera F, Price AM, Tsang DS, Esbenshade A, Ramaswamy V, Dirks PB, Dewan MC

Journal of neuro-oncology2026

DOI: 10.1007/s11060-026-05808-9 PMID: 42773286

TRAM-01: A phase 2 study of trametinib for pediatric patients with neurofibromatosis type 1 and plexiform neurofibromas.

Sadat Kiaei D, Caru M, Larouche V, Clini E, Pugalenthi Saravanan D, Lippé S, Théoret Y, Décarie JC, Tabori U, Hawkins C, Ellezam B, Ospina LH, Desjardins L, Métras MÉ, Sultan S, Cantin É, Routhier MÈ, Mailloux C, Bertrand MC, Estephan K, McKeown T, Vairy S, Legault G, Renzi S, Bouffet É, Ramaswamy V, Coltin H, Lafay-Cousin L, Hukin J, Alves M, Rent T, Erker C, Jabado N, Dehaes M, Perreault S

Neuro-oncology2026

DOI: 10.1093/neuonc/noag112 PMID: 42155032

A National Modified Delphi Consensus on the Referral and Management of NF1 Plexiform Neurofibroma.

Lafay-Cousin L, Perreault S, Singh D, Larner K, Ramaswamy V

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques2026Senior author

DOI: 10.1017/cjn.2025.10409 PMID: 40891257

Pediatric ependymoma in the molecular era: real-world experience with diagnostic correlation and long-term clinical outcomes.

Trkova K, Vicha A, Sumerauer D, Ghasemi DR, Ramaswamy V, Krskova L, Koblizek M, Zamecnik J, Kyncl M, Ondrova B, Stolova L, Rybkova M, Horcicakova K, Benes V, Rutkowski S, Zapotocky M

Journal of neuro-oncology2026

DOI: 10.1007/s11060-026-05740-y PMID: 42554912

BRAF Inhibition in Congenital Nevi and Neural Melanosis.

Doolan BJ, Levy R, McKeown T, Das A, Ramaswamy V

JAMA dermatology2026Senior author

DOI: 10.1001/jamadermatol.2026.1629 PMID: 42384401

Paediatric therapeutic development workshop on medulloblastoma.

Montiel Equihua C, Baxter JS, Molenaar JJ, Areso I, Abbou S, Anderson J, Andre N, Ayrault O, Blanc P, Carpenter N, Daems S, D'Angiolella V, Danielson L, Donovan L, Durbin AD, Fouladi M, Gajjar A, Gilbertson R, Giraud G, Gottardo N, Hill R, Kearns P, Kool M, Lass G, Marino S, Mueller S, Newman S, Olson J, Patel S, Pfister SM, Rainsbury J, Ramaswamy V, Rutkowski S, Straathof K, Swartling FJ, Wechsler-Reya RJ, Pearson ADJ, Jenkinson D, Doz F, Clifford SC, LifeArc, Innovative Therapies for Children with Cancer (ITCC), Cancer Research UK, Cancer Grand Challenge Protect team

British journal of cancer2026

DOI: 10.1038/s41416-026-03533-8 PMID: 42426296

From developmental origins to relapse: molecular and therapeutic insights in medulloblastoma.

Tourigny N, Fernandes da Silva C, Ramaswamy V

Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery2026Senior author

DOI: 10.1007/s00381-026-07368-9 PMID: 42414637

Reirradiation for Patients With Recurrent Ependymoma Across the Age Spectrum.

Sum YY, Bennett J, Ramaswamy V, Das A, Liu AP, Huang A, Tabori U, Dirks P, Nassiri F, Keilty DM, Tsang DS

Advances in radiation oncology2026

DOI: 10.1016/j.adro.2026.102039 PMID: 42179830

Integrated biomarker and treatment correlates of prognosis in infant non-WNT/non-SHH medulloblastoma: a multinational retrospective cohort study.

Richardson S, Hicks D, Gough M, Butler ER, Thompson D, Castle J, Crosier S, Garcia-Ariza M, Martín-Guerrero I, Plasschaert S, Bourdeaut F, Dufour C, Masliah-Planchon J, Buttarelli FR, Biassoni V, Massimino M, Ichimura K, Kanemura Y, Ramaswamy V, Gajjar A, Mynarek M, Rutkowski S, Kool M, Pfister SM, Korshunov A, Schwalbe EC, Bailey S, Clifford SC

The Lancet. Child & adolescent health2026

DOI: 10.1016/s2352-4642(26)00067-2 PMID: 42150584

Targeting Gene Fusions in Pediatric Brain Tumors: A Personalized Medicine Approach

Nominated PICIHR2025Project Grant

Principal investigators: Ramaswamy, Vijay; Charron, Frederic; Garzia, Livia

Keywords: Antisense Oligonucleotides; Ependymoma; Fusions; Medulloblastoma; Pediatric Cancer

$1,491,750

Exploiting therapeutic vulnerabilities to identify new treatments for high-risk SHH medulloblastoma

Nominated PICIHR2022Project Grant

Principal investigators: Ramaswamy, Vijay; Charron, Frederic

Keywords: Brain Cancer; Functional Genomics; Pediatric Cancer; Sonic Hedgehog; Therapeutics

$1,285,200

OPTIMISE: Optimal precision therapies to customise care in childhood and adolescent cancer

Co-investigatorCIHR2022Project Grant - Priority Announcement: Pediatric Cancer Research

Principal investigators: Morgenstern, Daniel A

Keywords: Early Phase Clinical Trials; Paediatric Oncology; Precision Medicine; Targeted Therapy

$545,625

Canadian Pediatric Cancer Consortium

Co-investigatorCIHR2022Team Grant: Pediatric Cancer Consortium

Principal investigators: David Malkin, James Whitlock; Co-Dyre, Adrienne; McIntosh, Keith A; Denburg, Avram E; Deyell, Rebecca J; Duval, Michel; Jabado, Nada; Marjerrison, Stacey L; Rayar, Meera; Tsimicalis, Argerie

Keywords: Cancer -Omics; Cancer Modeling; Clinical Trials; Community Engagement; Implementation Science; Innovative Therapies; Knowledge Mobilization; Pan-Canadian Consortium; Pediatric Cancer; Training And Mentorship

$23,000,000

Canada Research Chair - Tier 2

Nominated PICIHR2021Canada Research Chairs - CIHR Funded - Tier 2

Principal investigators: Ramaswamy, Vijay

Keywords: Crc

$600,000

Therapeutic Targeting of TP53 mutant Sonic Hedgehog Medulloblastoma

SupervisorCIHR2021Doctoral Research Award: Canada Graduate Scholarships

Principal investigators: DeCarlo, Alexandria L

Keywords: Crispr-Cas9; Epigenetic Screening; Genetic Sequencing; High-Throughput Drug Screening; Medulloblastoma; Radiotherapy; Therapy Sensitization

$105,000

Novel therapeutic targets for Group 3 medulloblastoma stem cells

Co-investigatorCIHR2020Project Grant

Principal investigators: Werbowetski-Ogilvie, Tamra E

Keywords: Animal Models; Cancer Stem Cells; Lineage Tracing; Medulloblastoma; Mtor Signaling; Otx2; Pax Genes; Pediatric Cancer; Single Cell Rna Sequencing

$1,208,700

Combined MEK inhibition and metronomic chemotherapy for recurrent/refractory paediatric low grade gliomas

Co-investigatorCIHR2019Project Grant

Principal investigators: Bouffet, Eric

Keywords: Braf Inhibitors; Mek Inhibitors; Paediatric Low Grade Gliomas; Progression Free Survival; Vinblastine

$1,526,175

Molecular and Functional Characterization of Childhood Ependymoma

Nominated PICIHR2018Project Grant

Principal investigators: Ramaswamy, Vijay

Keywords: Cancer; Ependymoma; Epigenetics; Genomics; Pediatric

$914,176

White matter plasticity in brain synchronisation and memory

Co-investigatorCIHR2017Project Grant

Principal investigators: Mabbott, Donald J

Keywords: Brain Injury; Computational Modelling; Meg; Memory; Mouse Models; Mri; Neural Oscillations; Paediatric Brain Tumour; Transgenic Approaches; White Matter Plasticity

$1,147,500

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Something wrong or missing on this profile? Suggest a correction

Vijay Ramaswamy

Research

Latest papers

Latest funding

Survival Outcomes and Complications Among Canadian Children With Retinoblastoma: A Population-Based Report From CYP-C.

Posterior fossa ependymoma: a comprehensive review of molecular classification, management guidelines, and clinical outcomes (Part I of ependymomas across compartments).

TRAM-01: A phase 2 study of trametinib for pediatric patients with neurofibromatosis type 1 and plexiform neurofibromas.

A National Modified Delphi Consensus on the Referral and Management of NF1 Plexiform Neurofibroma.

Pediatric ependymoma in the molecular era: real-world experience with diagnostic correlation and long-term clinical outcomes.

BRAF Inhibition in Congenital Nevi and Neural Melanosis.

Paediatric therapeutic development workshop on medulloblastoma.

From developmental origins to relapse: molecular and therapeutic insights in medulloblastoma.

Reirradiation for Patients With Recurrent Ependymoma Across the Age Spectrum.

Integrated biomarker and treatment correlates of prognosis in infant non-WNT/non-SHH medulloblastoma: a multinational retrospective cohort study.

Frequent collaborators

Eric Bouffet

Uri Tabori

Cynthia Hawkins

Ute Bartels

Annie Huang

Nada Jabado

David Malkin

Livia Garzia

Livia Garzia

Adam Shlien

Xi Huang

Nada Jabado

Birgit Ertl-Wagner

Birgit Ertl-Wagner

Donald Mabbott

Gelareh Zadeh

Sebastien Perreault

Sheila Singh

Adam Fleming

Boleslaw Lach

Kenneth Aldape

Michael Taylor

Lili-Naz Hazrati

James Drake

Mathieu Lupien

Sunit Das

James Rutka

David Hodgson

Valérie Larouche

Anna Goldenberg

Faiyaz Notta

Donna Johnston

Catherine Goudie

Farshad Nassiri

Janilyn Arsenio

Jean Michaud

Ahmed Aman

Abhaya Kulkarni

Ning Liu

Derek Tsang